NYSEAMERICAN : RGNT
Regentis Biomaterials Ltd. — Financial statements
Healthcare · Other · Israel
Last price 1.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 7.57M | 6.64M | 712.00K | 1.12M | 436.00K | 331.00K |
| Research & Development | 1.35M | 331.00K | -1.64M | 806.00K | 971.00K | 337.00K |
| Operating Expenses | 8.93M | 6.97M | -932.00K | 1.93M | 1.41M | 668.00K |
| Operating Income | -8.93M | -6.97M | 932.00K | -1.93M | -1.41M | -668.00K |
| Interest Expense | -79.00K | -79.00K | -10.00K | |||
| Currency Exchange Gain (Loss) | 71.00K | 71.00K | 96.00K | -68.00K | 257.00K | -16.00K |
| Other Non Operating Income (Expenses) | -6.82M | -6.67M | 3.78M | -2.13M | -299.00K | -4.46M |
| Pretax Income | -13.02M | -13.65M | 4.80M | -4.13M | -1.45M | -5.14M |
| Net Income | -13.02M | -13.65M | 4.80M | -4.13M | -1.45M | -5.14M |
| Preferred Dividends & Other Adjustments | 3.08M | 44.00K | 4.52M | 48.00K | 48.00K | 48.00K |
| Net Income to Common | -16.10M | -13.69M | 279.00K | -4.18M | -1.50M | -5.19M |
| Shares Outstanding (Basic) | 3.46M | 566.74K | 162.20K | 173.51K | 162.20K | 162.20K |
| Shares Outstanding (Diluted) | 3.46M | 566.74K | 162.20K | 173.51K | 162.20K | 162.20K |
| EPS (Basic) | -4.65 | -24.16 | 1.72 | -24.09 | -9.23 | -32.00 |
| EPS (Diluted) | -4.66 | -24.16 | 1.72 | -24.09 | -9.23 | -32.00 |
| EBIT | -8.93M | -6.97M | 932.00K | -1.93M | -1.41M | -668.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.95M | 7.38M | 229.00K | 345.00K | 1.24M | 2.74M |
| Cash & Short-Term Investments | 8.95M | 7.38M | 229.00K | 345.00K | 1.24M | 2.74M |
| Other Receivables | 230.00K | 73.00K | 8.00K | 26.00K | 45.00K | |
| Receivables | 230.00K | 73.00K | 8.00K | 26.00K | 45.00K | |
| Prepaid Expenses | 10.00K | 180.00K | 7.00K | 451.00K | 326.00K | |
| Total Current Assets | 9.29M | 7.62M | 482.00K | 360.00K | 1.72M | 3.12M |
| Total Assets | 9.35M | 7.62M | 482.00K | 360.00K | 1.72M | 3.12M |
| Accounts Payable | 195.00K | 266.00K | 252.00K | 353.00K | 206.00K | 308.00K |
| Accrued Expenses | 1.45M | 1.41M | 1.13M | 521.00K | 420.00K | 202.00K |
| Short-Term Debt | 1.20M | 573.00K | 210.00K | |||
| Current Portion of Long-Term Debt | 4.37M | 6.47M | ||||
| Current Unearned Revenue | 2.05M | 1.98M | 2.21M | |||
| Other Current Liabilities | 160.00K | 1.00K | 2.00K | 3.00K | ||
| Total Current Liabilities | 1.65M | 2.87M | 6.49M | 3.14M | 9.08M | 2.72M |
| Long-Term Debt | 7.41M | 6.08M | ||||
| Other Long-Term Liabilities | 623.00K | 685.00K | 785.00K | |||
| Total Liabilities | 1.67M | 2.87M | 6.49M | 11.17M | 9.77M | 9.58M |
| Additional Paid-In Capital | 66.08M | 60.54M | 1.04M | 1.04M | 754.00K | 754.00K |
| Retained Earnings | -58.39M | -55.79M | -42.15M | -46.95M | -42.81M | -41.23M |
| Total Common Equity | 7.68M | 4.74M | -41.10M | -45.91M | -42.06M | -40.48M |
| Shareholders' Equity | 7.68M | 4.74M | -6.01M | -10.81M | -8.05M | -6.47M |
| Total Liabilities & Equity | 9.35M | 7.62M | 482.00K | 360.00K | 1.72M | 3.12M |
| Total Debt | 29.00K | 1.20M | 4.95M | 7.62M | 6.47M | 6.08M |
| Net Cash (Debt) | 8.92M | 6.18M | -4.72M | -7.27M | -5.23M | -3.33M |
| Net Cash Per Share | 2.58 | 10.91 | -29.08 | -41.90 | -32.26 | -20.54 |
| Filing Date Shares Outstanding | 7.02M | 5.18M | 162.20K | 3.93M | 162.20K | 162.20K |
| Total Common Shares Outstanding | 7.02M | 5.18M | 162.20K | 162.20K | 162.20K | 162.20K |
| Working Capital | 7.63M | 4.74M | -6.01M | -2.78M | -7.36M | 392.00K |
| Book Value Per Share | 1.09 | 0.92 | -253.42 | -283.02 | -259.32 | -249.57 |
| Tangible Book Value | 7.68M | 4.74M | -41.10M | -45.91M | -42.06M | -40.48M |
| Tangible Book Value Per Share | 1.09 | 0.92 | -253.42 | -283.02 | -259.32 | -249.57 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -13.02M | -13.65M | 4.80M | -4.13M | -1.45M | -5.14M |
| Other Amortization | 245.00K | 245.00K | 161.00K | 173.00K | ||
| Stock-Based Compensation | 7.50M | 7.04M | ||||
| Other Operating Activities | 2.10M | 4.86M | -4.00M | 2.03M | 68.00K | 4.42M |
| Change in Accounts Payable | -24.00K | 14.00K | -101.00K | 147.00K | -102.00K | -25.00K |
| Change in Other Net Operating Assets | -648.00K | 117.00K | -1.50M | 562.00K | -21.00K | 878.00K |
| Operating Cash Flow | -3.84M | -1.38M | -641.00K | -1.22M | -1.50M | 130.00K |
| Short-Term Debt Issued | 300.00K | 400.00K | 325.00K | |||
| Long-Term Debt Issued | 450.00K | 1.24M | ||||
| Total Debt Issued | 300.00K | 850.00K | 325.00K | 1.24M | ||
| Short-Term Debt Repaid | -325.00K | |||||
| Total Debt Repaid | -1.20M | -325.00K | ||||
| Net Debt Issued (Repaid) | -1.20M | 300.00K | 525.00K | 325.00K | 1.24M | |
| Issuance of Common Stock | 13.84M | 8.22M | ||||
| Financing Cash Flow | 12.64M | 8.52M | 525.00K | 325.00K | 1.24M | |
| Net Cash Flow | 8.76M | 7.15M | -116.00K | -895.00K | -1.50M | 1.36M |
| Levered Free Cash Flow | 2.14M | 3.03M | -886.75K | -251.88K | -1.10M | 399.50K |
| Unlevered Free Cash Flow | 1.94M | 2.83M | -1.04M | -424.88K | -1.10M | 399.50K |
| Change in Working Capital | -672.00K | 131.00K | -1.60M | 709.00K | -123.00K | 853.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.62M | 34.91M | ||||
| Enterprise Value | 699.77K | 77.98M | ||||
| Last Close Price | 1.37 | 6.74 | ||||
| PB Ratio | 1.25 | 7.36 | ||||
| P/TBV Ratio | 1.25 | 7.36 | ||||
| Debt / Equity Ratio | 0.00 | 0.25 | -0.82 | -0.70 | -0.80 | -0.94 |
| Net Debt / Equity Ratio | -1.16 | -1.30 | -0.79 | -0.67 | -0.65 | -0.52 |
| Quick Ratio | 5.42 | 2.65 | 0.05 | 0.11 | 0.14 | 1.02 |
| Current Ratio | 5.62 | 2.65 | 0.07 | 0.12 | 0.19 | 1.14 |
| Return on Assets (ROA) | -113.59% | -107.53% | 138.36% | -116.21% | -36.40% | -18.55% |
| Return on Capital Employed (ROCE) | -116.00% | -146.90% | -15.50% | 69.50% | 19.10% | -170.40% |
| Earnings Yield | -339.85% | -39.10% | ||||
| Buyback Yield / Dilution | -2,034.86% | -249.41% | 6.52% | -6.97% |